1-2 of 2
Matt Barnett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph+ Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients.

Nicola Esposito, PhD, Concetta Quintarelli, PhD, Irene Colavita, PhD, Barbara Izzo, PhD, Anna Lucia Peluso, PhD, Margherita Ruoppolo, PhD, Luigi Del Vecchio, MD, Domenico Russo, Susan Branford, PhD, Ilaria Iacobucci, PhD, Mark Thornquist, Matt Barnett, Junia Melo, Giuseppe Saglio, Jerald Radich, Lin Peter, Giovanni Martinelli, Thea Kalebic, MD, Timothy Hughes, Fabrizio Pane
Journal: Blood
Blood (2009) 114 (22): 2212.
https://doi.org/10.1182/blood.V114.22.2212.2212
Published: 2009
Journal Articles

Association Between Imatinib (IM) Transporters and Metabolizing Enzymes Genotype and Response in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients (Pts) Is Influenced by Ethnicity.

Simona Soverini, PhD, Sabrina Angelini, Eleonora Turrini, Fabrizio Pane, MD, Fabrizio Quarantelli, Timothy P. Hughes, MD, MBBS, Deborah L White, PhD, Dong Wook Kim, Harriet Goh, Jerald Radich, Lan Beppu, Giuseppe Saglio, Daniela Cilloni, MD, Carolina Terragna, Sandra Durante, Ilaria Iacobucci, PhD, Giovanni Perini, Ph.D., Patrizia Hrelia, Giorgio Cantelli Forti, Thea Kalebic, MD, Matt Barnett, Mark Thornquist, Michele Baccarani, MD, Giovanni Martinelli
Journal: Blood
Blood (2009) 114 (22): 3283.
https://doi.org/10.1182/blood.V114.22.3283.3283
Published: 2009